Discover the latest science based breakthroughs
in health, medicine and new drug approvals
Discover the latest science based breakthroughs in health, medicine and new drug approvals
Latest Posts
ScienceMyHealth delivers the latest updates on new drug approvals and groundbreaking medical research from the Food and Drug Administration, leading scientific journals, and top universities.
With new stories and videos posted daily, subscribers can stay informed and receive alerts to explore and find clinical trials relevant to their interests.
Receive the Latest Medical Breakthroughs to Your Inbox
Subscribe to the latest health news, medical research, and informed analysis.
Trending News
The Hidden Long-Term Effects of Chemotherapy in Older Breast Cancer Survivors
Thanks to advances in breast cancer treatment, more women are living longer after their diagnosis than ever before. But as survival rates improve, researchers are paying closer attention to what happens after treatment ends. For many survivors, the effects of...
Could a New Discovery Prevent Muscle Loss and Weakness as We Age?
Muscle weakness is one of the biggest challenges of aging. As people get older, they naturally lose muscle strength and muscle mass, a condition known as sarcopenia. This can make everyday activities like climbing stairs, carrying groceries, or getting up from a chair much more difficult. While exercise and good nutrition remain the best ways to slow muscle loss, researchers are searching for new treatments that target the underlying causes of age-related muscle weakness.
Could Glucosamine Supplements Worsen Alzheimer’s Disease? Here’s What Researchers Found
Many people take glucosamine supplements every day to help support their joints. It has been used for years and is one of the most popular supplements for osteoarthritis. However, a new study is raising questions about whether glucosamine could affect brain health in people with Alzheimer’s disease or mild cognitive impairment.
The Facts on Tampons and Tampon Safety
Tampons are absorbent products that you insert into your vagina to soak up menstrual flow during your period. Tampons come in different absorbency levels — like light, regular, and super — so you can pick the right one for your flow. Some have a plastic or cardboard applicator to help with insertion, and others are inserted with your finger.
Health Research News Update
Xylitol was linked to a higher risk of heart attack, stroke, or cardiovascular death.
Paracetamol, also called acetaminophen, taken during pregnancy was linked to smaller ovaries and fewer egg-containing follicles in daughters.
And a review study found that for esophageal cancer, adding surgery after chemoradiation was linked to better survival than chemoradiation alone.
First Gene Therapy for Pediatric Patients with Sanfilippo Syndrome Type A Approved
Fayuvi is a one-time, intravenous (given directly into a vein) gene therapy that uses a modified, non-infectious virus called an adeno-associated virus serotype 9 (AAV9) to deliver a working copy of the SGSH gene into the patient’s cells. This enables the body’s cells to produce sulfamidase — the enzyme that is missing or deficient in MPS IIIA — allowing heparan sulfate to be properly broken down in lysosomes and reducing its harmful buildup throughout the body and brain.
Inherited Cancer Risk- Experimental Cancer Vaccine Shows Promise for People With Lynch Syndrome
People with Lynch syndrome face a much higher lifetime risk of developing colorectal cancer and several other cancers. Current prevention strategies rely heavily on regular screenings, surveillance, and in some cases preventive surgery. A new study suggests that a cancer-prevention vaccine may one day become another tool for reducing that risk.
A Hidden Subtype of Endometrial Cancer – What Subtypes Mean for Cancer Care
A new systematic review and meta-analysis is helping shine a spotlight on one of the least understood groups: high-grade endometrioid endometrial cancers with no specific molecular profile (NSMP). The findings suggest that this subtype represents nearly one-third of high-grade endometrial cancers and may play an important role in the future of personalized cancer care.




























